Connor, Clark & Lunn Investment Management Ltd.
Position in NEO — Neogenomics Inc
CIK 1596800
VANCOUVER, A1
Position in NEO
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$6,960,345
-$3,364,335 QoQ
Shares Held
938,052
+6.8% QoQ
Ownership
0.720%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NEO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Connor, Clark & Lunn Investment Management Ltd. holds $206,312,128 across 18 Diagnostics & Research names. NEO ranks #8 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MEDP |
Medpace Holdings, Inc.
|
134,838 | $64,747,859 | |
| 2 | ILMN |
Illumina, Inc.
|
202,742 | $24,989,978 | |
| 3 | DHR |
Danaher Corp /De/
|
129,426 | $24,539,169 | |
| 4 | GH |
Guardant Health, Inc.
|
254,788 | $23,534,767 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
|
54,570 | $9,413,325 | |
| 6 | CSTL |
Castle Biosciences Inc
|
377,082 | $9,257,363 | |
| 7 | ADPT |
Adaptive Biotechnologies Corp
|
649,627 | $9,016,822 | |
| 8 | NEO |
Neogenomics Inc
This page
|
938,052 | $6,960,345 |
All Filings in NEO
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,960,345 | 938,052 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $10,324,680 | 877,949 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $4,317,842 | 559,306 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $507,752 | 69,460 | Shares | Sole | 2025-08-07 | |
| No filing history on record for this holder in this stock. | ||||||